Rhodobacter capsulatus PG Lipopolysaccharide Blocks the Effects of a Lipoteichoic Acid, a Toll-Like Receptor 2 Agonist
- PMID: 36694898
- PMCID: PMC9844088
- DOI: 10.32607/actanaturae.11747
Rhodobacter capsulatus PG Lipopolysaccharide Blocks the Effects of a Lipoteichoic Acid, a Toll-Like Receptor 2 Agonist
Abstract
Lipopolysaccharides (LPS) and lipoteichoic acids (LTA) are the major inducers of the inflammatory response of blood cells caused by Gram-negative and some Gram-positive bacteria. CD14 is a common receptor for LPS and LTA that transfers the ligands to TLR4 and TLR2, respectively. In this work, we have demonstrated that the non-toxic LPS from Rhodobacter capsulatus PG blocks the synthesis of pro-inflammatory cytokines during the activation of blood cells by Streptococcus pyogenes LTA through binding to the CD14 receptor, resulting in the signal transduction to TLR2/TLR6 being blocked. The LPS from Rhodobacter capsulatus PG can be considered a prototype for developing preparations to protect blood cells against the LTA of gram-positive bacteria.
Keywords: CD14; Rhodobacter capsulatus; TLR; cytokines; lipopolysaccharide; lipoteichoic acid.
Copyright ® 2022 National Research University Higher School of Economics.
Figures





References
-
- Ginsburg L.. Lancet. Infect. Dis. 2002;2(3):171–179. - PubMed
-
- Schwandner R., Dziarski R., Wesche H., Rothe M., Kirschning C.J.. J. Biol. Chem. 1999;274(25):17406–17409. - PubMed
-
- Schroder N.W.J., Morath S., Alexander C., Hamann L., Hartung T., Zahringer U., Gobel U.B., Weber J.R., Schumann R.R., Biol. Chem. 2003;278(18):15587–15594. - PubMed
-
- Im J., Choi H.S., Kim S.K., Woo S.S., Ryu Y.H., Kang S.S., Yun C.H., Han S.H.. Cancer Lett. 2009;274(1):109–117. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials